Smartphone-based digital assessments in the LUMA trial of BIIB122/DNL151 for early-stage Parkinson’s disease

R. Llorens Arenas

International Congress of Parkinson’s Disease and Movement Disorders, 2025, October 5-9, Hawaii, USA

‹ Indivi Secures CHF 15 Million Investment to Accelerate the Discovery of Treatment Response Biomarkers in Neuroscience Drug Development, Targeting Alzheimer’s Disease

Enhancing Step Detection in Real-World Gait ›